Bank of New York Mellon’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Sell |
51,734
-802
| -2% | -$15.1K | ﹤0.01% | 3302 |
|
|
2026
Q1 | $918K | Sell |
52,536
-2,044
| -4% | -$40.6K | ﹤0.01% | 3262 |
|
|
2025
Q4 | $1.07M | Sell |
54,580
-32,412
| -37% | -$672K | ﹤0.01% | 3197 |
|
|
2025
Q3 | $2.4M | Sell |
86,992
-1,915
| -2% | -$58.9K | ﹤0.01% | 2703 |
|
|
2025
Q2 | $2.71M | Buy |
88,907
+4,862
| +6% | +$138K | ﹤0.01% | 2599 |
|
|
2025
Q1 | $2.27M | Sell |
84,045
-209
| -0.2% | -$6.62K | ﹤0.01% | 2632 |
|
|
2024
Q4 | $3.02M | Sell |
84,254
-4,816
| -5% | -$180K | ﹤0.01% | 2562 |
|
|
2024
Q3 | $3.38M | Sell |
89,070
-8,305
| -9% | -$341K | ﹤0.01% | 2492 |
|
|
2024
Q2 | $4.41M | Buy |
97,375
+5,205
| +6% | +$239K | ﹤0.01% | 2392 |
|
|
2024
Q1 | $4.47M | Sell |
92,170
-11,586
| -11% | -$567K | ﹤0.01% | 2381 |
|
|
2023
Q4 | $5.56M | Sell |
103,756
-11,973
| -10% | -$606K | ﹤0.01% | 2307 |
|
|
2023
Q3 | $6.78M | Sell |
115,729
-7,112
| -6% | -$445K | ﹤0.01% | 2166 |
|
|
2023
Q2 | $7.74M | Buy |
122,841
+3,047
| +3% | +$194K | ﹤0.01% | 2079 |
|
|
2023
Q1 | $7.54M | Sell |
119,794
-7,341
| -6% | -$438K | ﹤0.01% | 2081 |
|
|
2022
Q4 | $6.76M | Buy |
127,135
+7,427
| +6% | +$402K | ﹤0.01% | 2160 |
|
|
2022
Q3 | $6.71M | Buy |
119,708
+6,693
| +6% | +$442K | ﹤0.01% | 2139 |
|
|
2022
Q2 | $8.18M | Sell |
113,015
-6,461
| -5% | -$481K | ﹤0.01% | 2058 |
|
|
2022
Q1 | $9.49M | Sell |
119,476
-81
| -0.1% | -$7.3K | ﹤0.01% | 2090 |
|
|
2021
Q4 | $12.1M | Sell |
119,557
-12,985
| -10% | -$1.3M | ﹤0.01% | 1998 |
|
|
2021
Q3 | $12.2M | Buy |
132,542
+1,769
| +1% | +$170K | ﹤0.01% | 2019 |
|
|
2021
Q2 | $13.4M | Sell |
130,773
-5,140
| -4% | -$516K | ﹤0.01% | 1973 |
|
|
2021
Q1 | $13.3M | Buy |
135,913
+3,216
| +2% | +$293K | ﹤0.01% | 1940 |
|
|
2020
Q4 | $10.2M | Sell |
132,697
-1,810
| -1% | -$140K | ﹤0.01% | 1994 |
|
|
2020
Q3 | $9.91M | Sell |
134,507
-10,281
| -7% | -$825K | ﹤0.01% | 1860 |
|
|
2020
Q2 | $10.6M | Sell |
144,788
-7,119
| -5% | -$558K | ﹤0.01% | 1797 |
|
|
2020
Q1 | $8.77M | Sell |
151,907
-4,498
| -3% | -$313K | ﹤0.01% | 1767 |
|
|
2019
Q4 | $12.3M | Buy |
156,405
+11,142
| +8% | +$821K | ﹤0.01% | 1853 |
|
|
2019
Q3 | $9.93M | Sell |
145,263
-19,813
| -12% | -$1.33M | ﹤0.01% | 1941 |
|
|
2019
Q2 | $13.1M | Buy |
165,076
+10,448
| +7% | +$829K | ﹤0.01% | 1800 |
|
|
2019
Q1 | $13M | Buy |
154,628
+64,019
| +71% | +$6.68M | ﹤0.01% | 1825 |
|
|
2018
Q4 | $10.7M | Sell |
90,609
-21,248
| -19% | -$2.46M | ﹤0.01% | 1856 |
|
|
2018
Q3 | $13.5M | Sell |
111,857
-254
| -0.2% | -$31.5K | ﹤0.01% | 1866 |
|
|
2018
Q2 | $12.9M | Buy |
112,111
+20,510
| +22% | +$2.24M | ﹤0.01% | 1873 |
|
|
2018
Q1 | $7.87M | Buy |
91,601
+7,469
| +9% | +$578K | ﹤0.01% | 2110 |
|
|
2017
Q4 | $6.23M | Sell |
84,132
-8,005
| -9% | -$535K | ﹤0.01% | 2238 |
|
|
2017
Q3 | $5.32M | Buy |
92,137
+1,944
| +2% | +$115K | ﹤0.01% | 2309 |
|
|
2017
Q2 | $5.78M | Buy |
90,193
+10,670
| +13% | +$657K | ﹤0.01% | 2258 |
|
|
2017
Q1 | $4.58M | Sell |
79,523
-109,147
| -58% | -$6.52M | ﹤0.01% | 2375 |
|
|
2016
Q4 | $11.5M | Buy |
188,670
+11,544
| +7% | +$752K | ﹤0.01% | 1878 |
|
|
2016
Q3 | $12.3M | Sell |
177,126
-3,646
| -2% | -$241K | ﹤0.01% | 1763 |
|
|
2016
Q2 | $10.1M | Sell |
180,772
-7,774
| -4% | -$469K | ﹤0.01% | 1845 |
|
|
2016
Q1 | $11.4M | Buy |
188,546
+10,814
| +6% | +$637K | ﹤0.01% | 1754 |
|
|
2015
Q4 | $11.4M | Sell |
177,732
-6,874
| -4% | -$446K | ﹤0.01% | 1770 |
|
|
2015
Q3 | $12.4M | Sell |
184,606
-11,404
| -6% | -$806K | ﹤0.01% | 1733 |
|
|
2015
Q2 | $13.4M | Sell |
196,010
-1,334
| -0.7% | -$84.7K | ﹤0.01% | 1780 |
|
|
2015
Q1 | $11M | Buy |
197,344
+106,708
| +118% | +$5.47M | ﹤0.01% | 1900 |
|
|
2014
Q4 | $4.65M | Sell |
90,636
-16,416
| -15% | -$806K | ﹤0.01% | 2349 |
|
|
2014
Q3 | $3.94M | Sell |
107,052
-37,766
| -26% | -$1.36M | ﹤0.01% | 2459 |
|
|
2014
Q2 | $5.66M | Sell |
144,818
-231,920
| -62% | -$8.61M | ﹤0.01% | 2260 |
|
|
2014
Q1 | $14.2M | Sell |
376,738
-2,576
| -0.7% | -$90K | ﹤0.01% | 1677 |
|
|
2013
Q4 | $14.3M | Sell |
379,314
-554
| -0.1% | -$21.2K | ﹤0.01% | 1676 |
|
|
2013
Q3 | $16.5M | Sell |
379,868
-36,152
| -9% | -$1.45M | ﹤0.01% | 1524 |
|
|
2013
Q2 | $15.1M | Buy |
+416,020
| New | +$12.6M | ﹤0.01% | 1562 |
|
Other funds holding USNA
N
SO
UA
Bank of New York Mellon's USNA Position: Q2 2026 in Review
Bank of New York Mellon reduced its Usana Health Sciences (USNA) stake by 1.5% in Q2 2026, selling an estimated $15.1K and leaving 51,734 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3302.
Bank of New York Mellon first reported a position in USNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.5M in Q3 2013. 61 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- Bank of New York Mellon held 51,734 shares of Usana Health Sciences worth $1.1M as of Q2 2026.
- Bank of New York Mellon sold 802 Usana Health Sciences shares in Q2 2026, an estimated $15.1K.
- Usana Health Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3302 holding.
- Bank of New York Mellon first reported a position in Usana Health Sciences in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Usana Health Sciences position peaked at $16.5M in Q3 2013.
- 61 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.